Elissa S. Cote

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elissa S. Cote:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. Chief Corp Development Officer Stock Option (Right to Buy) 150,000 23 Jun 2025 Direct

Insider Reports Filed by Elissa S. Cote

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VTGN Vistagen Therapeutics, Inc. 23 Jun 2025 1 $0 4 Chief Corp Development Officer 25 Jun 2025, 17:16
VTGN Vistagen Therapeutics, Inc. 23 Jun 2025 0 $0 3 Chief Corp Development Officer 25 Jun 2025, 17:15